Use of darunavir in HIV-infected women during pregnancy
The use of antiretroviral drugs (ARVDs) in a mother and a child can reduce the risk of vertical transmission of human immunodeficiency virus (HIV) to less than 1%; therefore, highly active antiretroviral therapy is used in all pregnant women regardless of indications for HIV-infection treatment. The...
Main Authors: | L Iu Afonina, E E Voronin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2013-11-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31405 |
Similar Items
-
Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis
by: Keith Dunn, et al.
Published: (2021-07-01) -
Unique Flap Conformation in an HIV-1 Protease with High-level Darunavir Resistance
by: Masaaki eNakashima, et al.
Published: (2016-02-01) -
Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure
by: Alberton F, et al.
Published: (2024-04-01) -
Intranasal delivery of darunavir improves brain drug concentrations in mice for effective HIV treatment
by: Asit Kumar, et al.
Published: (2023-03-01) -
WAYS TO ELIMINATION OF MOTHER-TO-CHILD TRANSMISSION OF HIV
by: N. V. Kozyrina, et al.
Published: (2018-12-01)